Alico (ALCO) Insider Notice: 31,250 Shares to Be Sold via Virtu Americas
Rhea-AI Filing Summary
A notice under Rule 144/A reports a proposed sale of 31,250 shares of Alico Inc. common stock through broker Virtu Americas, LLC on 08/15/2025. The filing gives an aggregate market value of $1,025,313 for the shares and lists 7,645,360 shares outstanding.
The shares were acquired on 11/12/2019 as a pro rata distribution from 734 Investors, LLC to Rinyami, LLC; the filing notes Mr. Slack is the Managing Member of Rinyami, LLC. The filer reports no securities sold in the past three months and affirms no undisclosed material adverse information.
Positive
- Full disclosure of proposed sale: number of shares (31,250), aggregate market value ($1,025,313), sale date (08/15/2025), and exchange (NASDAQ) are provided
- Clear acquisition history: shares were acquired 11/12/2019 via pro rata distribution from 734 Investors, LLC to Rinyami, LLC; managing member identified
- No recent dispositions: filer reports "Nothing to Report" for securities sold during the past three months
Negative
- None.
Insights
TL;DR: Routine insider sale notice; modest slice of outstanding shares disclosed with clear acquisition history and broker.
The filing documents a scheduled sale that represents a small portion of the company's outstanding common stock (31,250 shares versus 7,645,360 shares outstanding). The disclosure includes acquisition date and origin, which helps trace beneficial ownership change. No sales in the past three months reduces concerns about concurrent disposition activity. This filing is informational and appears routine rather than materially market-moving.
TL;DR: Proper Rule 144/A disclosure of proposed sale with manager identity and provenance; governance transparency met.
The form identifies the source of the securities and the managing member of the transferee entity, aiding transparency about related-party relationships. The attestation that no undisclosed material adverse information exists is standard. There are no indications of regulatory or compliance issues within the disclosed fields.